Stereoscopic digital mammography: Improved specificity and reduced rate of recall in a prospective clinical trial

Carl J. D'Orsi, David J. Getty, Ronald M. Pickett, Ioannis Sechopoulos, Mary S. Newell, Kathleen R. Gundry, Sandra R. Bates, Robert M. Nishikawa, Edward A. Sickles, Andrew Karellas, Ellen M. D'Orsi

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Purpose: To compare stereoscopic digital mammography (DM) with standard DM for the rate of patient recall and the detection of cancer in a screening population at elevated risk for breast cancer. Materials and Methods: Starting in September 2004 and ending in December 2007, this prospective HIPAA-compliant, institutional review board-approved screening trial, with written informed consent, recruited female patients at elevated risk for breast cancer (eg, personal history of breast cancer or breast cancer in a close relative). A total of 1298 examinations from 779 patients (mean age, 58.6 years; range, 32-91 years) comprised the analyzable data set. A paired study design was used, with each enrolled patient serving as her own control. Patients underwent both DM and stereoscopic DM examinations in a single visit, findings of which were interpreted independently by two experienced radiologists, each using a Breast Imaging Reporting and Data System (BI-RADS) assessment (BI-RADS category 0, 1, or 2). All patients determined to have one or more findings with either or both modalities were recalled for standard diagnostic evaluation. The results of 1-year follow-up or biopsy were used to determine case truth. Results: Compared with DM, stereoscopic DM showed significantly higher specificity (91.2% [1167 of 1279] vs 87.8% [1123 of 1279]; P = .0024) and accuracy (90.9% [1180 of 1298] vs 87.4% [1135 of 1298]; P = .0023) for detection of cancer. Sensitivity for detection of cancer was not significantly different for stereoscopic DM (68.4% [13 of 19]) compared with DM (63.2% [12 of 19], P > .99). The recall rate for stereoscopic DM was 9.6% (125 of 1298) and that for DM was 12.9% (168 of 1298) (P = .0018). Conclusion: Compared with DM, stereoscopic DM significantly improved specificity for detection of cancer, while maintaining comparable sensitivity. The recall rate was significantly reduced with stereoscopic DM compared with DM.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalRadiology
Volume266
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Stereoscopic digital mammography: Improved specificity and reduced rate of recall in a prospective clinical trial'. Together they form a unique fingerprint.

  • Cite this

    D'Orsi, C. J., Getty, D. J., Pickett, R. M., Sechopoulos, I., Newell, M. S., Gundry, K. R., Bates, S. R., Nishikawa, R. M., Sickles, E. A., Karellas, A., & D'Orsi, E. M. (2013). Stereoscopic digital mammography: Improved specificity and reduced rate of recall in a prospective clinical trial. Radiology, 266(1), 81-88. https://doi.org/10.1148/radiol.12120382